Who: I’m working with Molten Ventures Fund of Funds, specialising in European funds, investing in Pre-Seed and Seed stage deals. To date, we have backed +70 funds @MoltenVentures
Do you think Series C+ killed the IPO exits?
I believe that the more capital there is, that helps unprofitable companies remain so while getting valued on growth, the less “benefit” there is to go public.
From simple growth oriented to quarterly reporting on marginal bp gains 🥵
I sat down with our biggest investor @louicop
We had a conversation about life, work and taboos in VC
All while eating very hot chicken wings
(2:20) describe this picture
(3:35) best advice Louis ever received
(5:53) worst job he ever had
(8:15) most wtf pitch deck
(11:05) taboos in the VC industry
(13:04) eco-consciousness
(15:29) a feature in June
(18:32) hot sauce kicks in 🌶🌶🌶
(19:10) EU in the AI war
(21:27) founder-investor relationship
(23:24) what would you want to be remembered for?
Tag an investor you’d like to get closer with
I’ll pick a tweet and send you a pack of ‘Hot Ones’ sauces
Thank you @Siftedeu for the coverage.
While we are looking to raise and build our next generation of FoF, one thing is certain: we will continue to back the best and most innovative early stage European VC managers.
@MoltenVentures
https://t.co/0dyKpIjNPU
For those working with AI, are you seeing large corporates wanting to become clients of startups to get ahead of this new tech wave, or are you seeing the contrary? In which corporates are less likely to become customers of startups and waiting to see if startups survive.
“Until 2020, we knew close to 1m combination of protein shapes. Since then, we have now have a catalog of 8m different protein shapes” Steve Crossnan from Dayhoff Labs speaking about the power of AI on Life Sciences
@Moonfire_VC#MoonfirePulse
“Facebook makes $6 of net income per user. HSBC’s retail banking section makes $150 of net income per client” Nick Brito from @dst_global speaking about the power of financial services
@Moonfire_VC#MoonfirePulse
@ninacapital “wasteful spending drives innovation” - the main driver behind their numerous investments in clinical research technologies.
💊What it takes to bring a new drug to market:
⏳15 years
💸$1.5-2bn
@ninacapital presenting the need to understand path to enterprise sales, as customers are decreasingly willing to “take a bet” on a startup that may not be around for long due to market difficulties
@ric0seq@nexhealthHQ@tryVital @ProcuroS Super work! Do you think there will be a boom, or even new categories of APIs emerging, with the likes of ChatGPT powering the calls? Or hard to tell the difference between hype and real atm?